x

Lexeo Therapeutics, Inc. (Nasdaq:LXEO)

Health Care/Life Sciences • Biotechnology
CIK 1907108
Company

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.

Address
345 Park Avenue South
6th floor
New York, New York 10010
Employees
None
Stock Info
Close
$14.73
Day Range
12.31 - 15.19
52 Week Range
9.00 - 22.33
Average volume
97.56K
Short Interest
352.02K (02/15/24)
% of Float Shorted
2.20%
Market Cap
$392.49M
Revenue
$654K
Net Income
-$59.28M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
N/A
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
R Nolan Townsend MBA
Chairman
Steven M Altschuler MD
Independent Director
Brenda Cooperstone MD
Independent Director
Reinaldo M Diaz MBA
Independent Director
Paula H. J Cholmondeley CPA
Independent Director
Bernard Davitian MBA, CPA
Independent Director
Mette Kirstine Agger MBA
SEC filings
DateFormEvent
15 Oct, 2024 4
9 Oct, 2024 8-K
9 Oct, 2024 424B3
11 Sep, 2024 4
10 Sep, 2024 144
13 Aug, 2024 4
12 Aug, 2024 424B3
12 Aug, 2024 8-K
12 Aug, 2024 10-Q
9 Aug, 2024 SC 13G/A
5 Aug, 2024 SC 13G/A
15 Jul, 2024 424B3
15 Jul, 2024 8-K
12 Jul, 2024 4
8 Jul, 2024 4
8 Jul, 2024 8-K
8 Jul, 2024 3
8 Jul, 2024 424B3
28 Jun, 2024 8-K
28 Jun, 2024 424B3
27 Jun, 2024 4
27 Jun, 2024 4
27 Jun, 2024 4
27 Jun, 2024 4
27 Jun, 2024 4
14 Jun, 2024 4
12 Jun, 2024 4
22 May, 2024 3
14 May, 2024 4
13 May, 2024 144
9 May, 2024 8-K
9 May, 2024 10-Q
9 May, 2024 424B3
26 Apr, 2024 DEF 14A
26 Apr, 2024 DEFA14A
26 Apr, 2024 ARS
22 Apr, 2024 8-K
22 Apr, 2024 8-K
22 Apr, 2024 424B3
22 Apr, 2024 424B3
16 Apr, 2024 8-K
16 Apr, 2024 424B3
12 Apr, 2024 424B3
12 Apr, 2024 EFFECT
11 Apr, 2024 UPLOAD
11 Apr, 2024 CORRESP
9 Apr, 2024 S-1
11 Mar, 2024 8-K
11 Mar, 2024 10-K
11 Mar, 2024 S-8
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G
13 Feb, 2024 SC 13G
6 Feb, 2024 4
6 Feb, 2024 4
6 Feb, 2024 3
6 Feb, 2024 4
5 Feb, 2024 8-K
9 Jan, 2024 4
9 Jan, 2024 4
18 Dec, 2023 8-K
15 Dec, 2023 SC 13G/A
11 Dec, 2023 SC 13G
11 Dec, 2023 10-Q
11 Dec, 2023 8-K
24 Nov, 2023 SC 13G
17 Nov, 2023 SC 13G
9 Nov, 2023 4
9 Nov, 2023 4
9 Nov, 2023 4
9 Nov, 2023 4
7 Nov, 2023 S-8
7 Nov, 2023 8-K
6 Nov, 2023 424B4 IPO completed
6 Nov, 2023 SEC STAFF
3 Nov, 2023 FWP
2 Nov, 2023 EFFECT
2 Nov, 2023 CERT
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
1 Nov, 2023 8-A12B
1 Nov, 2023 UPLOAD
1 Nov, 2023 S-1/A
1 Nov, 2023 CORRESP
31 Oct, 2023 CORRESP
31 Oct, 2023 CORRESP
30 Oct, 2023 S-1/A
5 Oct, 2023 CORRESP
29 Sep, 2023 S-1
19 Sep, 2023 SEC STAFF
18 Sep, 2023 DRSLTR
18 Sep, 2023 DRS/A
18 Aug, 2023 UPLOAD
16 Aug, 2023 DRS/A
15 Aug, 2023 DRSLTR
13 Jun, 2023 UPLOAD
17 May, 2023 DRSLTR
17 May, 2023 DRS/A
17 May, 2022 UPLOAD
5 May, 2022 DRSLTR
5 May, 2022 DRS/A
3 Mar, 2022 UPLOAD
4 Feb, 2022 DRS
Last update:2024-03-06 12:12:07.553069
Lexeo Therapeutics, Inc. by TradingView

Sign Up to Subscribe